Macquarie Group’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Macquarie Group’s Portfolio MRTX Stock Details MRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-60,000	Closed	-$3.53M	–	1961
2023 Q4	$3.53M	Hold	60,000	–	–	﹤0.01%	1058
2023 Q3	$2.61M	Hold	60,000	–	–	﹤0.01%	1089
2023 Q2	$2.17M	Hold	60,000	–	–	﹤0.01%	1163
2023 Q1	$2.23M	Hold	60,000	–	–	﹤0.01%	1129
2022 Q4	$2.72M	Sell	60,000 -638	-1%	-$28.9K	﹤0.01%	1115
2022 Q3	$4.26M	Sell	60,638 -417	-0.7%	-$29.3K	0.01%	1031
2022 Q2	$4.1M	Sell	61,055 -9,043	-13%	-$607K	﹤0.01%	1086
2022 Q1	$5.76K	Buy	70,098 +288	+0.4%	+$24	﹤0.01%	1078
2021 Q4	$10.2M	Buy	69,810 +212	+0.3%	+$31.1K	0.01%	928
2021 Q3	$12.3M	Sell	69,598 -2,725	-4%	-$482K	0.01%	872
2021 Q2	$11.7M	Sell	72,323 -9,451	-12%	-$1.53M	0.01%	899
2021 Q1	$14M	Sell	81,774 -12,234	-13%	-$2.1M	0.02%	633
2020 Q4	$20.6M	Sell	94,008 -25,787	-22%	-$5.66M	0.03%	507
2020 Q3	$19.9M	Sell	119,795 -65,376	-35%	-$10.9M	0.03%	470
2020 Q2	$21.1M	Buy	185,171 +6,900	+4%	+$788K	0.04%	452
2020 Q1	$13.7M	Hold	178,271	–	–	0.03%	496
2019 Q4	$23M	Sell	178,271 -57,659	-24%	-$7.43M	0.03%	479
2019 Q3	$18.4M	Buy	235,930 +12,300	+6%	+$958K	0.03%	467
2019 Q2	$23M	Hold	223,630	–	–	0.04%	429
2019 Q1	$16.4M	Hold	223,630	–	–	0.03%	516
2018 Q4	$9.49M	Hold	223,630	–	–	0.02%	606
2018 Q3	$10.5M	Sell	223,630 -1,500	-0.7%	-$70.7K	0.02%	636
2018 Q2	$11.1M	Buy	225,130 +1,500	+0.7%	+$74K	0.02%	612
2018 Q1	$6.87M	Buy	223,630 +143,030	+177%	+$4.39M	0.01%	692
2017 Q4	$1.47M	Buy	80,600 +600	+0.8%	+$11K	﹤0.01%	1117
2017 Q3	$936K	Hold	80,000	–	–	﹤0.01%	1232
2017 Q2	$292K	Hold	80,000	–	–	﹤0.01%	1376
2017 Q1	$416K	Hold	80,000	–	–	﹤0.01%	1348
2016 Q4	$380K	Hold	80,000	–	–	﹤0.01%	1369
2016 Q3	$529K	Sell	80,000 -80,000	-50%	-$529K	﹤0.01%	1281
2016 Q2	$874K	Buy	+160,000	New	+$874K	﹤0.01%	1303